Please login to the form below

Not currently logged in
Email:
Password:

MINE

This page shows the latest MINE news and features for those working in and with pharma, biotech and healthcare.

The five-step, rare disease-ready checklist

The five-step, rare disease-ready checklist

Monitor the competition. Create a clinical trial tracker that mines all relevant competitor data from clinicaltrials.gov and investor materials.

Latest news

  • Relics from the past Relics from the past

    But this month, as I hosted an online conference, those two topics overlapped with a third passion of mine, the life sciences industry, to point to the way our business is

  • Bayer's drop of the future Bayer's drop of the future

    desire. So when I read One Drop’s website and positioning, it was a little bit spooky – not unlike when I read a childhood diary of mine in which I recorded

  • The mother of all nudges The mother of all nudges

    And what of another favourite topic of mine, health literacy? Telling people to ‘shelter in place’ is all fine and well.

  • Deep Value Deep Value

    Darwin was in my thoughts as I struggled with something a prospective PhD student of mine was talking about. ... In a flash, I could see that Dr Topol’s thinking was convergently evolving in the same direction as mine.

  • Pharma Careers Q&A: Caroline Benson Pharma Careers Q&A: Caroline Benson

    Trusted Advisor’ by David Maister is a favourite of mine. I recommend it to anyone working in client service; even though it was written approximately 20 years ago, the principles stand

More from news
Approximately 1 fully matching, plus 49 partially matching documents found.

Latest Intelligence

  • Working together against COVID-19 Working together against COVID-19

    A colleague of mine recently wrote a passionate piece in which she highlighted, in the midst of all the strategies and tactics of pharma marketing, education and comms, it is important

  • AI UK – one year on AI UK – one year on

    September, which looked explicitly at the role of radiologists – the specialists long- considered to be the canary in the AI coal mine.

  • Open minds for open innovation Open minds for open innovation

    Clearly identify the problem that needs solving and ensure alignment. In order to do this, you need to have the right information to fully understand the challenge - collect and mine data

  • The true potential of mobile health tech The true potential of mobile health tech

    Open minds. Syneos is active in a number of projects tracking the impact of a variety of digital engagements and measurements of conditions to mine a deeper sense of patients than

  • AI’s potential in the pharma life cycle AI’s potential in the pharma life cycle

    That’s because advanced algorithms powered by huge computing resources can combine and mine vast sources of global data to identify significant clues compared with even the most-experienced clinicians, who ... Researchers here too are increasingly

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics